PRACTICAL ONCOLOGY JOURNAL ›› 2012, Vol. 26 ›› Issue (3): 256-258.doi: 10.3969/j.issn.1002-3070.2012.03.016

Previous Articles     Next Articles

Application of etomidate and propofol infusion in benign breast tumors operation

CHI Meng1,LI Shijie2,ZHANG Peizhong3,WANG Guonian1   

  1. 1.Department of Anesthesiology,The Third Affiliated Hospital of Harbin Medical University,Harbin 150081;
    2.Company of China north oil field general hospital;
    3.Department of Anesthesiology,The First Affiliated Hospital Nanyang Medical College
  • Received:2011-11-23 Online:2012-06-28 Published:2014-12-03

PDF (PC)

81

Abstract: Objective To explore the efficacy and side effect of target controlled infusion(TCI)of etomidate in benign breast tumors operation.Methods Sixty patients undergoing benign breast tumors operation were randomly divided into two groups(n=30):etomidate group(group E),etomidate were given by TCI targeting effect-site(0.3μg/mL);propofol group(group P),propofol were given by TCI targeting effect-site(3μg/mL).The two groups were all given midazolam 2~3mg,sufentanyl by TCI targeting effect-site(0.1ng/mL).The HR,ECG,SpO2 and MAP in two groups were continuously monitored during the study.Respiratory depression,myoclonus,post operation nausea and vomiting were recorded.Results Compared with group P,group E had more stabilized hemodynamics(P＜0.05),lower respiratory depression incidence(P＜0.05)and higher sedation degree(P＜0.05).There was no significant difference in myoclonus between them,but the Group E has higner incidence than group P in post operation nausea and vomiting.Conclusion Both etomidate and propofol given by target controlled infusion can be safely used in benign breast tumors,but the etomidated group had more stabilized hemodynamics and lower respiratory depression incidence than propofol group.Besides,group E had higher incidence of postoperative nausea and vomiting.

Key words: Etomidate, Propofol, Benign breast tumors, Target controlled infusion

CLC Number: